Skip to main content
July 22, 2024
SGS Nutrasource is pleased to announce that Microbio has received an Independent / Self-Affirmed GRAS for their Symbiota® ingredient. Symbiota® is a soybean fermentate using a combination of 19 bacterial strains and the yeast Saccharomyces cerevisiae or mixtures of these strains.
“The achievement of Independent / Self-affirmed GRAS for Symbiota® is a key market access strategy to U.S.,” said Dr. Tzen-Wen Chen, Chairman and General Manger. “Unlike probiotics, this GRAS conclusion is the first on postbiotics in Taiwan, and the GRAS conclusion will include the soybean fermentates generated by multi-strain probiotics and yeasts or mixtures of these strains, which covers all current Microbio’s proprietary microbiome based portfolio. The GRAS Associates team is very thoughtful and approachable for the entire process. We are so grateful to work with them on the project.”
Symbiota® can be used in nutritional beverages, protein and nutritional powders, smoothies, and grain drinks, regular and diet sports and energy drinks, regular and diet soft drinks, fruit drinks including unreconstituted powders, dairy drinks, and milk substitutes, gelatin-type candies, ready to eat cereals, and cooked cereals at usage levels up to 20% for the liquid form and 10% for the powdered form.
Amy Mozingo, Vice President of GRAS Associates (a SGS Nutrasource company), notes, “The Microbio team’s expertise and understanding of their ingredient was invaluable in producing a robust dossier and GRAS conclusion for the intended use of Symbiota®. The GRAS Associates team was pleased to work with Microbio in drafting the dossier and managing the Expert Panel review process.”
Congratulations to Microbio on this achievement.
About Symbiota®
Symbiota® products are the cutting-edge “postbiotics” meticulously developed with Microbio’s proprietary symbiotic anaerobic fermentation technology using multi-strain probiotics, such as Lacticaseibacillus paracasei, Lactobacillus delbrueckii subsp. bulgaricus, Bifidobacterium longum, and Saccharomyces cerevisiae. All microorganisms used in manufacturing are listed as NHPs by Health Canada and have received QPS designations from EFSA. The individual Symbiota® products made with different bacteria strains are as follows : “MS-20” approved for use as a adjuvant in the traditional Chinese medicine category by the Taiwan FDA; “PrimeEnzyme” available in Cotton-Field Organic; “Young”, a Taiwan FDA certified health food with the functions for immune regulation (A00064), blood lipid modulation (A00082), and gastrointestinal function improvement (A00062); and two newly-developed microbiome-based products, “TB90010” for blood glucose support and “LT17” for liver support.
About Microbio Co., Ltd.
Microbio is a public-listed biotech company on Taipei Stock Exchange (Ticker: 4128). Since its inception in May 2000, Microbio has been dedicated to the research and development of cutting-edge products, including new drugs, medical foods and novel medical devices based on its proprietary symbiotic anaerobic fermentation technology.